PMID: 19642168

Keitel V, Burdelski M, Vojnisek Z, Schmitt L, Haussinger D, Kubitz R
De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis.
Hepatology. 2009 Aug;50(2):510-7., [PubMed]
Sentences
No. Mutations Sentence Comment
29 ABCB11 p.Val444Ala
X
ABCB11 p.Val444Ala 19642168:29:118
status: NEW
view ABCB11 p.Val444Ala details
ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:29:158
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:29:137
status: NEW
view ABCB11 p.Tyr818Phe details
Compared to the reference sequence NM_003742 of BSEP (ABCB11), three homozygous missense changes were found: 1331T3C (V444A),17 2453A3T (Y818F), and 2944G3A (G982R)4 (start codon numbered as "1"). Login to comment
79 ABCB11 p.Val444Ala
X
ABCB11 p.Val444Ala 19642168:79:141
status: NEW
view ABCB11 p.Val444Ala details
The construct contained three silent mutations (2190G3A, 3210A3G, 3516C3C) and one mutation (1331T3C), leading to an amino acid replacement (V444A). Login to comment
81 ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:81:209
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:81:138
status: NEW
view ABCB11 p.Tyr818Phe details
The patient`s mutations were introduced using the Quickchange-Multisite- mutagenesis kit (Stratagene) and the following primers: 2453A3T (Y818F): 5Ј-ccaatttctacagggatttgcctttgctaaatc- 3Ј; 2944G3A (G982R): 5Ј-cagaaagccaatatttacagattctgctt- tgcctttgc-3Ј. Login to comment
150 ABCB11 p.Val444Ala
X
ABCB11 p.Val444Ala 19642168:150:30
status: NEW
view ABCB11 p.Val444Ala details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:150:39
status: NEW
view ABCB11 p.Tyr818Phe details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:150:163
status: NEW
view ABCB11 p.Tyr818Phe details
Introduction of the mutations V444A or Y818F separately or together into BSEP-YFP had no apparent effect on the localization of BSEPV444A, BSEPY818F, or BSEPV444A/Y818F as compared to wild-type BSEP-YFP (Fig. 2A, 4A). Login to comment
151 ABCB11 p.Val444Ala
X
ABCB11 p.Val444Ala 19642168:151:67
status: NEW
view ABCB11 p.Val444Ala details
ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:151:25
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:151:142
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:151:163
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:151:76
status: NEW
view ABCB11 p.Tyr818Phe details
However, introduction of G982R alone or in combination with either V444A or Y818F (Fig. 4B) resulted in the retention of BSEPG982R, BSEPV444A/G982R, and BSEPY818F/G982R in the endoplasmic reticulum (ER) in colocalization with the ER marker protein disulfide isomerase. Login to comment
152 ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:152:78
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:152:72
status: NEW
view ABCB11 p.Tyr818Phe details
Combining all three mutations resulted in nondetectability of BSEPV444A/Y818F/G982R-YFP (Fig. 4C) independent of the cell type used (Supporting Fig. 3). Login to comment
154 ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:154:117
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:154:110
status: NEW
view ABCB11 p.Tyr818Phe details
Unexpectedly, K165 and K168 immunoreactivity, but no YFP fluorescence, was present in aggresomes of BSEPV444A/Y818F/ G982R-YFP-transfected cells after MG-132 treatment (Fig. 4G,J). Login to comment
165 ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:165:44
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:165:38
status: NEW
view ABCB11 p.Tyr818Phe details
Bars ϭ 10 ␮m. BSEPV444A/Y818F/G982R-YFP within the ER-associated degradation pathway. Login to comment
166 ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:166:138
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:166:132
status: NEW
view ABCB11 p.Tyr818Phe details
Furthermore, the apparent loss of YFP fluorescence is suggestive of an incomplete expression or a major folding defect of BSEPV444A/Y818F/G982R-YFP. Login to comment
175 ABCB11 p.Val444Ala
X
ABCB11 p.Val444Ala 19642168:175:99
status: NEW
view ABCB11 p.Val444Ala details
ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:175:39
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:175:49
status: NEW
view ABCB11 p.Tyr818Phe details
It is of note, that in addition to the G982R and Y818F mutations, the common mutation/polymorphism V444A is necessary for the complete disappearance of BSEP. Login to comment
176 ABCB11 p.Val444Ala
X
ABCB11 p.Val444Ala 19642168:176:0
status: NEW
view ABCB11 p.Val444Ala details
ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:176:299
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:176:293
status: NEW
view ABCB11 p.Tyr818Phe details
V444A has a high prevalence in the Caucasian population,17 has been linked to the development of drug-induced liver injury,30 and may aggravate cholestatic liver diseases such as intrahepatic cholestasis of pregnan- cy31 or benign recurrent intrahepatic cholestasis.32 Expression of BSEPV444A/Y818F/G982R in hepatic and nonhepatic cell lines was below detectability. Login to comment
184 ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:184:16
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:184:74
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:184:26
status: NEW
view ABCB11 p.Tyr818Phe details
The presence of G982R and Y818F caused the retention of mutated BSEPY818F/G982R-YFP within the endoplasmic reticulum. Login to comment
185 ABCB11 p.Val444Ala
X
ABCB11 p.Val444Ala 19642168:185:51
status: NEW
view ABCB11 p.Val444Ala details
ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:185:63
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:185:122
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:185:57
status: NEW
view ABCB11 p.Tyr818Phe details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:185:116
status: NEW
view ABCB11 p.Tyr818Phe details
Combination of all three mutations of the patient (V444A,Y818F,G982R) induced complete absence of mutated BSEPV444A/Y818F/G982R-YFP. Login to comment
188 ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:188:54
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:188:55
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:188:248
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Gly982Arg
X
ABCB11 p.Gly982Arg 19642168:188:249
status: NEW
view ABCB11 p.Gly982Arg details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:188:48
status: NEW
view ABCB11 p.Tyr818Phe details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:188:49
status: NEW
view ABCB11 p.Tyr818Phe details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:188:242
status: NEW
view ABCB11 p.Tyr818Phe details
ABCB11 p.Tyr818Phe
X
ABCB11 p.Tyr818Phe 19642168:188:243
status: NEW
view ABCB11 p.Tyr818Phe details
(G-L) Aggresomes, induced by MG132 in BSEPV444A/Y818F/G982R-YFP-expressing cells, contained immunoreactivity for the BSEP antibodies K165 (I) and K168 (L) but no green fluorescence, suggesting incomplete expression or misfolding of BSEPV444A/Y818F/G982R-YFP. Login to comment